Navigation Links
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease
Date:7/8/2010

NEW YORK, July 8 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) will present new data on its investigational compounds targeting various aspects of Alzheimer's disease (AD), a complex degenerative brain disorder.  New findings on the role of comorbidities, the burden of care and costs associated with AD, also will be discussed. These data, some in collaboration with our partners, will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (ICAD 2010) in Honolulu, July 10-15.  

(Logo:  http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO )

"Biomedical research and development is very risky; for every new medicine that makes it to market, thousands must be screened in discovery. For a complex condition such as Alzheimer's disease, which has multiple factors contributing to its onset and progression, the challenges are even greater," said Steve Romano, vice president, medical affairs head, Pfizer Primary Care Business Unit.  "The breadth of data being presented at ICAD
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014  According to their CEO, Rob ... trials is going through a complete transformation with ... of the current clinical trial management process isn,t ... clinical trials, which will ultimately drive the prescription ... company has been recognized by the National Cancer ...
(Date:9/30/2014)... 30, 2014   Easy Breathe , the fastest ... announced that it now offers the revolutionary AirSense ... the first sleep apnea therapy devices with internal cellular ... to track and share real-time data on each user,s ... CPAP therapy.  In addition, the internal modem allows the ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... National Parkinson Foundation (NPF) and the ... to evaluate Kinetic,s Objective Parkinson,s Disease Measurement (OPDM) system ... of Parkinson,s disease (PD).  The evaluation will take place ... groundbreaking Quality Improvement Initiative (QII). "It ...
... AT&T * and Zephyr Technology today announced ... to the next generation of the Zephyr BioHarness™ designed ... breathing rate, skin temperature, then contextualize the information with ... is then viewed through the Zephyr portal or pushed ...
Cached Medicine Technology:Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 2Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 3AT&T to Wirelessly Connect Zephyr BioHarness 2AT&T to Wirelessly Connect Zephyr BioHarness 3AT&T to Wirelessly Connect Zephyr BioHarness 4
(Date:10/1/2014)... 01, 2014 Join the more than 80 ... Treatment Center’s first ever charity golf tournament to benefit Project ... eating disorders who cannot afford treatment. The tournament will be ... Eureka, Mo. , The day-long event starts with 10:30 ... and award dinner will begin at 5 p.m. and will ...
(Date:10/1/2014)... Beverly Hills, California (PRWEB) October 01, 2014 ... relationship expert, Dr. Kathleen Mojas is celebrating 20 years ... she has assisted hundreds of people to achieve greater ... released an important list of warning signs and suggestions ... relationship. , Dr. Mojas explains: “Believe it or ...
(Date:10/1/2014)... Jupiter, FL (PRWEB) October 01, 2014 ... Begley, Jr., scheduled to broadcast on Monday, October 20, ... In this episode, Innovations will go behind the scenes ... prevention programs. This segment will explore the practical help ... young adults, which teaches the warning signs of abuse, ...
(Date:10/1/2014)... Inc., announced today their new NoteSwift™ 2.0 for Allscripts ... the bridge between the EHR and Dragon Medical interpreting ... at the point of care. NoteSwift reduces the time ... than half – and virtually eliminates mouse clicks – ... EHR use according to the June 12, 2014 HIMSS ...
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2
... a biotech lab in Korea. He was told that he was ... pet dog, his beloved family mutt, Missy. Now one year old, ... the good life in Mill Valley, California. “Not only does she ... same, and she has some of the same quirks that made ...
... become standard, researchers say , , FRIDAY, Dec. 5 (HealthDay ... better determine whether a breast lesion detected by MRI ... unnecessary biopsies, say U.S. researchers. , They reviewed almost ... the Seattle Cancer Care Alliance and identified three important ...
... Sense, Will Stimulate Economy, Save Lives , ... Administration,s proposed truck clean-up rule, which the California Air Resources ... much-needed boost to the economy and cut billions of dollars ... Californians. , , "The ...
... 6 months appears most effective, Australian study finds , , ... possible to control the progression of cystic fibrosis through ... infants, according to Australian researchers. , They found that ... early as infancy, even though lung function shortly after ...
... December 5, 2008 REGiMMUNE Corporation, a ... and products for immune disorders, will present preclinical ... Graft versus Host Disease (GvHD) at the American ... 6 through 9 in San Francisco, California. REGiMMUNE ...
... Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced Lauren ... in a panel discussion on "Adapting Specialty Pharma Strategy to ... panel will begin at 10:00 a.m. Eastern Time on Wednesday, ... , To access the live ...
Cached Medicine News:Health News:Cloned Canine Celebrates Her 1st Birthday 2Health News:New Statistical Model Could Cut Needless Breast Biopsies 2Health News:Proposed Truck Clean-Up Rule Will Save Billions in Health-Related Costs for Truckers and Other Californians 2Health News:Aggressive Therapy May Stem CF Progression in Infants 2
... IS2s DCC camera is optimized for cardiac imaging ... dual-view planar studies. Resolution and image quality are ... to the front of the gantry is clear ... bicycles or treadmills for dual view gated cardiac ...
... optimum head hyperextension, open airway, and a firm ... at strategic locations throughout the hospital, the Thumper ... immediately, and easy conversion to Thumper CPR ... done in less than 30 seconds. ,Slide the ...
... The Paradigm Pachymetric Analyzer is designed ... employing unique digital signal processing algorithms. During ... a reading if the probe is +1.5 ... assured of highly accurate results, every time. ...
NIDEK's US-1800 is an industry leader offering both combination pachymeter and ultrasound functionalities. The unit features and includes the latest IOL power calculation software, a touch screen pan...
Medicine Products: